Key facts
| Price (PPV) | 6,373 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | romiplostim |
| Class | Antihemorrhagics |
| ATC code | B02BX04 |
| Manufacturer | SOTHEMA |
| Presentation | 1 flacon de 5 ml |
| Nature | Médicament |
| Hospital price | 6,149 MAD |
| Data collected on | 9/8/2026 |
Indications
Nplate est indiqué chez les patients adultes présentant une thrombopénie immunologique primaire (PTI), réfractaire aux autres traitements (par exemple corticoïdes, immunoglobulines)
Find an open pharmacy
On-call pharmacies near you
About Nplat 250 µg
Nplat 250 µg belongs to the antihemorrhagics therapeutic class. In Morocco, this drug is marketed by SOTHEMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Nplat 250 µg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Nplat 250 µg
Answers to common questions from Moroccan patients about this drug.